Glimp-M1

Glimp-M1 is a combination of Metformin Hydrochloride and Glimepiride tablets, used in the treatment of type 2 diabetes mellitus. It helps control blood sugar levels and prevents complications such as kidney damage, heart problems, nerve issues, and blindness caused by uncontrolled diabetes.

• Glimepiride is a sulfonylurea that increases insulin release from the pancreas, helping lower blood glucose.

• Metformin is a biguanide that decreases glucose production in the liver and improves the body’s sensitivity to insulin.

Together, they provide effective control of blood sugar, reduce insulin resistance, and support long-term diabetes management.